Anti-inflammatory effects of low-dose oral theophylline in atopic asthma

P. Sullivan, Z. Jaffar, C. Page, J. Costello, S. Bekir, P. Jeffery

Research output: Contribution to journalArticlepeer-review

397 Scopus citations


Theophylline, in addition to its bronchodilator effect, may attenuate inflammation in asthma. We did a double-blind placebo-controlled study of the effect of oral theophylline on the inflammatory response of the bronchial mucosa to inhalation of allergen in 19 atopic asthmatic subjects. Bronchoscopy and bronchial biopsy were done 24 hours after allergen inhalation before and after six weeks of treatment with oral slow-release theophylline, 200 mg 12 hourly. The mean serum concentration was 36·6 μmol/L, which is below the currently-accepted therapeutic range. After treatment with theophylline there was a significant reduction in the number of EG2-positive activated eosinophils (5·9 before and 2·1 after treatment, Wilcoxon signed rank p < 0 05) and total eosinophils (16·7 before and 7 6 after treatment, p < 0·05) beneath the epithelial basement membrane. We conclude that low-dose oral theophylline attenuates airway inflammatory response to allergen inhalation in atopic asthma.

Original languageEnglish
Pages (from-to)1006-1008
Number of pages3
JournalThe Lancet
Issue number8904
StatePublished - Apr 23 1994


Dive into the research topics of 'Anti-inflammatory effects of low-dose oral theophylline in atopic asthma'. Together they form a unique fingerprint.

Cite this